Published in Exp Brain Res on April 01, 1998
Predictive modeling by the cerebellum improves proprioception. J Neurosci (2013) 1.27
Cerebellar motor learning: are environment dynamics more important than error size? J Neurophysiol (2013) 0.95
Effects of accuracy constraints on reach-to-grasp movements in cerebellar patients. Exp Brain Res (2000) 0.86
Is tracing or copying better when learning to reproduce a pattern? Exp Brain Res (2010) 0.86
Bilateral representation in the deep cerebellar nuclei. J Physiol (2008) 0.86
Cerebellar damage diminishes long-latency responses to multijoint perturbations. J Neurophysiol (2013) 0.83
Predicting and correcting ataxia using a model of cerebellar function. Brain (2014) 0.81
Cerebellar damage produces context-dependent deficits in control of leg dynamics during obstacle avoidance. Exp Brain Res (2004) 0.78
A New Method for Functional Evaluation of Motor Commands in Patients with Cerebellar Ataxia. PLoS One (2015) 0.75
Physical Therapy for a Patient with Essential Tremor and Prolonged Deep Brain Stimulation: A Case Report. Tremor Other Hyperkinet Mov (N Y) (2017) 0.75
Glutathione, oxidative stress and neurodegeneration. Eur J Biochem (2000) 3.11
Cholesterol and Alzheimer's disease: is there a link? Neurology (2001) 2.79
Cerebellar encephalitis in adults. J Neurol (1993) 2.30
Sublethal irradiation promotes migration and invasiveness of glioma cells: implications for radiotherapy of human glioblastoma. Cancer Res (2001) 2.26
The natural history of degenerative ataxia: a retrospective study in 466 patients. Brain (1998) 2.11
Oxidative stress in patients with Friedreich ataxia. Neurology (2000) 2.03
Differential effects of central verses peripheral vision on egocentric and exocentric motion perception. Exp Brain Res (1973) 1.98
Deficiency of inducible nitric oxide synthase protects against MPTP toxicity in vivo. J Neurochem (2000) 1.78
Visual control of arm movement in Parkinson's disease. Mov Disord (1994) 1.69
Moving visual scenes influence the apparent direction of gravity. Science (1972) 1.62
Adult onset glutaric aciduria type I presenting with a leukoencephalopathy. Neurology (2002) 1.60
Quantification of postural sway in normals and patients with cerebellar diseases. Electroencephalogr Clin Neurophysiol (1984) 1.57
Magnetic resonance imaging in hereditary and idiopathic ataxia. Neurology (1993) 1.55
Quantitative analysis of stance in late cortical cerebellar atrophy of the anterior lobe and other forms of cerebellar ataxia. Brain (1979) 1.51
The significance of proprioception on postural stabilization as assessed by ischemia. Brain Res (1984) 1.48
Anticipation in familial cavernous angioma: ascertainment bias or genetic cause. Acta Neurol Scand (1998) 1.46
Increased serum levels of soluble CD95 (APO-1/Fas) in relapsing-remitting multiple sclerosis. Ann Neurol (1998) 1.45
Magnetic resonance imaging-based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy. Ann Neurol (1999) 1.44
Cerebellar ataxia in ataxic hemiparesis? A kinematic and EMG analysis. Mov Disord (1993) 1.43
Mechanisms underlying recovery of eye-head coordination following bilateral labyrinthectomy in monkeys. Exp Brain Res (1973) 1.42
Multiple system atrophy: natural history, MRI morphology, and dopamine receptor imaging with 123IBZM-SPECT. J Neurol Neurosurg Psychiatry (1994) 1.41
[Neuronal protection in neurologic diseases?]. Nervenarzt (1994) 1.38
One week on/one week off: a novel active regimen of temozolomide for recurrent glioblastoma. Neurology (2004) 1.36
Manifestation of Hashimoto's encephalopathy years before onset of thyroid disease. Eur Neurol (1999) 1.36
The aetiology of sporadic adult-onset ataxia. Brain (2002) 1.34
Locoregional Apo2L/TRAIL eradicates intracranial human malignant glioma xenografts in athymic mice in the absence of neurotoxicity. Biochem Biophys Res Commun (1999) 1.33
On the role of vestibular, visual and somatosensory information for dynamic postural control in humans. Prog Brain Res (1988) 1.31
BCL-2 family protein expression in initial and recurrent glioblastomas: modulation by radiochemotherapy. J Neurol Neurosurg Psychiatry (1999) 1.29
The development toward stereotypic arm kinematics during reaching in the first 3 years of life. Exp Brain Res (1997) 1.29
Secreted Frizzled-related proteins inhibit motility and promote growth of human malignant glioma cells. Oncogene (2000) 1.26
Early stabilization of human posture after a sudden disturbance: influence of rate and amplitude of displacement. Exp Brain Res (1984) 1.25
Predicting chemoresistance in human malignant glioma cells: the role of molecular genetic analyses. Int J Cancer (1998) 1.25
A defect of kinesthesia in Parkinson's disease. Mov Disord (1995) 1.23
Autosomal dominant cerebellar ataxia type I. MRI-based volumetry of posterior fossa structures and basal ganglia in spinocerebellar ataxia types 1, 2 and 3. Brain (1998) 1.23
Variability of postural "reflexes" in humans. Exp Brain Res (1983) 1.22
Some methods and parameters of body sway quantification and their neurological applications. Arch Psychiatr Nervenkr (1970) (1980) 1.22
Autosomal dominant cerebellar ataxia type I: oculomotor abnormalities in families with SCA1, SCA2, and SCA3. J Neurol (1999) 1.21
The effect of lateral head tilt on horizontal postrotatory nystagmus I and II and the Purkinje effect. Acta Otolaryngol (1985) 1.20
The development of goal-directed reaching in infants: hand trajectory formation and joint torque control. Exp Brain Res (1995) 1.20
Classical conditioning after cerebellar lesions in humans. Behav Neurosci (1993) 1.19
Characteristic alterations of long-loop "reflexes" in patients with Friedreich's disease and late atrophy of the cerebellar anterior lobe. J Neurol Neurosurg Psychiatry (1984) 1.19
Motion habituation: inverted self-motion perception and optokinetic after-nystagmus. Exp Brain Res (1974) 1.19
Subcutaneous sumatriptan in the treatment of headache during withdrawal from drug-induced headache. Headache (1991) 1.18
Functional coupling of human cortical sensorimotor areas during bimanual skill acquisition. Brain (1999) 1.18
Gluteal compartment syndrome due to rhabdomyolysis after heroin abuse. Neurology (1997) 1.17
The origin of contraversive pushing: evidence for a second graviceptive system in humans. Neurology (2000) 1.14
Tonic pupil, areflexia, and segmental anhidrosis: two additional cases of Ross syndrome and review of the literature. J Neurol (1992) 1.13
Postural sway in normals and atactic patients: analysis of the stabilising and destabilizing effects of vision. Agressologie (1976) 1.12
HSV-2 sacral radiculitis (Elsberg syndrome). Neurology (2004) 1.12
Stenosis and occlusion of the subclavian artery: ultrasonographic and clinical findings. J Neurol (1987) 1.12
Cerebrospinal fluid interleukins, immunoglobulins, and fibronectin in neuroborreliosis. Arch Neurol (1991) 1.12
Ocular myasthenia gravis: response to long-term immunosuppressive treatment. J Neurol Neurosurg Psychiatry (1997) 1.11
Adult medulloblastoma: prognostic factors and response to therapy at diagnosis and at relapse. J Neurol (2005) 1.11
Idiopathic cerebellar ataxia of late onset: natural history and MRI morphology. J Neurol Neurosurg Psychiatry (1990) 1.08
Vascular endothelial growth factor (VEGF) in leptomeningeal metastasis: diagnostic and prognostic value. Br J Cancer (2004) 1.08
The influence of normal aging on the cortical processing of a simple motor task. Neurology (2000) 1.08
Decorin gene transfer-mediated suppression of TGF-beta synthesis abrogates experimental malignant glioma growth in vivo. Gene Ther (1998) 1.07
Spinocerebellar ataxia type 5: clinical and molecular genetic features of a German kindred. Neurology (2004) 1.07
Autosomal dominant cerebellar ataxia type I clinical features and MRI in families with SCA1, SCA2 and SCA3. Brain (1996) 1.07
Impaired suppression of vestibular nystagmus by fixation in cerebellar and noncerebellar patients. Arch Psychiatr Nervenkr (1970) (1978) 1.07
Adjustment of saccade characteristics during head movements. Exp Brain Res (1973) 1.06
The role of mitochondrial dysfunction and neuronal nitric oxide in animal models of neurodegenerative diseases. Mol Cell Biochem (1997) 1.06
Visual input improves the speedometer function of the vestibular nuclei in the goldfish. Exp Brain Res (1973) 1.06
Changes of cerebrovascular CO2 reactivity during normal aging. Stroke (1998) 1.06
The spatial frequency effect on perceived velocity. Vision Res (1976) 1.06
Body oscillations in balancing due to segmental stretch reflex activity. Exp Brain Res (1980) 1.05
Betulinic acid-induced apoptosis in glioma cells: A sequential requirement for new protein synthesis, formation of reactive oxygen species, and caspase processing. J Pharmacol Exp Ther (1999) 1.05
Transforming growth factors beta(1) (TGF-beta(1)) and TGF-beta(2) promote glioma cell migration via Up-regulation of alpha(V)beta(3) integrin expression. Biochem Biophys Res Commun (2000) 1.05
CCM1 gene mutations in families segregating cerebral cavernous malformations. Neurology (2001) 1.05
Central visual, acoustic, and motor pathway involvement in a Charcot-Marie-Tooth family with an Asn205Ser mutation in the connexin 32 gene. J Neurol Neurosurg Psychiatry (1999) 1.05
Effects of rectilinear acceleration and optokinetic and caloric stimulations in space. Science (1984) 1.04
Cognitive deficits in spinocerebellar ataxia type 1, 2, and 3. J Neurol (2003) 1.04
Spontaneous occlusion of a bilateral caroticocavernous fistula studied by serial angiography. Neuroradiology (1971) 1.03
The neural representation of postural control in humans. Proc Natl Acad Sci U S A (2000) 1.03
BCL-2 family protein expression in human malignant glioma: a clinical-pathological correlative study. J Neurol Sci (1998) 1.02
Pathophysiology of cerebellar ataxia. Mov Disord (1992) 1.02
Fas/CD95/Apo-I activates the acidic sphingomyelinase via caspases. Cell Death Differ (1998) 1.02
Vestibular neuritis spares the inferior division of the vestibular nerve. Brain (1996) 1.02
[Familial juvenile glio-neural dystrophy. Acutely beginning progressive encephalopathy with right-side occipitol-parietal focal symptoms and status epilepticus]. Arch Psychiatr Nervenkr (1970) (1969) 1.01
Optokinetic motion sickness and pseudo-Coriolis effects induced by moving visual stimuli. Acta Otolaryngol (1973) 1.01
Cortical self-regulation in patients with epilepsies. Epilepsy Res (1993) 1.01
Space exploration in neglect. Brain (1998) 1.00
Central pontine myelinolysis associated with low potassium levels in alcoholism. J Neurol (1990) 1.00
BCL-2 promotes migration and invasiveness of human glioma cells. FEBS Lett (1998) 1.00
Optokinetic-graviceptive interaction in different head positions. Acta Otolaryngol (1975) 0.99
Lesion-symptom mapping of the human cerebellum. Cerebellum (2008) 0.98
Late-onset myasthenia gravis. Follow-up of 113 patients diagnosed after age 60. Ann N Y Acad Sci (1998) 0.98
Comparative analysis of cytokine patterns in immunological, infectious, and oncological neurological disorders. J Neurol Sci (1991) 0.98
Cognitive deficits in spinocerebellar ataxia 2. Brain (1999) 0.98
Medium- and long-latency responses to displacements of the ankle joint in patients with spinal and central lesions. Electroencephalogr Clin Neurophysiol (1985) 0.98
Extended therapeutic window for caspase inhibition and synergy with MK-801 in the treatment of cerebral histotoxic hypoxia. Cell Death Differ (1998) 0.97
Sporadic cerebellar ataxia associated with gluten sensitivity. Brain (2001) 0.97
GluR3 antibodies: prevalence in focal epilepsy but no specificity for Rasmussen's encephalitis. Neurology (2001) 0.97
Analgesic-induced chronic headache: long-term results of withdrawal therapy. J Neurol (1989) 0.96
Ocular myasthenia gravis. A critical review of clinical and pathophysiological aspects. Doc Ophthalmol (1993) 0.96
Surviving glioblastoma for more than 5 years: the patient's perspective. Neurology (2006) 0.96
Aspirin non-responder status in patients with recurrent cerebral ischemic attacks. J Neurol (2003) 0.96
Expression and functional activity of heat shock proteins in human glioblastoma multiforme. Neurology (2000) 0.95
Gait initiation in Parkinson's disease. Mov Disord (1997) 0.94